Modified WHO classification of maternal cardiovascular risk: application

WHO II-III (depending on individual)-Small increased risk of maternal mortality or moderate increase in morbidity.
• Marfan syndrome without aortic dilatation
• Aorta < 45 mm in aortic disease associated with bicuspid aortic valve
• Repaired coarctation
WHO III-Significantly increased risk of maternal mortality or severe morbidity. Expert counselling required. If pregnancy is decided upon, intensive specialist cardiac and obstetric monitoring needed throughout pregnancy, childbirth, and the puerperium.
• Aortic dilatation 40–45 mm in Marfan syndrome
• Aortic dilatation 45–50 mm in aortic disease associated with bicuspid aortic valve
WHO IV-Extremely high risk of maternal mortality or severe morbidity; pregnancy contraindicated. If pregnancy occurs termination should be discussed. If pregnancy continues, care as for class III.
• Severe systemic ventricular dysfunction (LVEF < 30%, NYHA III–IV)
• Marfan syndrome with aorta dilated > 45 mm
• Aortic dilatation > 50 mm in aortic disease associated with bicuspid aortic valve
• Native severe coarctation

LVEF: left ventricular ejection fraction; NYHA: New York Heart Association; WHO: World Health Organization